Skip to content
StockMarketAgent
Direct answer
IDXX trades against a final fair-value range of $231.99-$439.23, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $232, high $439, with mid-point at $335.
Stock analysis

IDXX IDXX fair value $232–$439

IDXX
By StockMarketAgent.AI team· supervised by
已分析: 2026-05-13下次更新: 2026-08-13Methodology v2.5Review: automatedArchetype: Mature compounder
View archive
股价
$533.92
▼ -198.84 (-37.24%)
公允价值
$335
$232–$439
评级
卖出
confidence 79/100
上行空间
-37.2%
upside to fair value
安全边际
$284.82
MoS level · 15%
市值
$42.1B
P/E fwd 32.4
英文原文ZH
翻译期间显示英文原文
此报告尚未翻译。翻译队列赶上后请在几分钟内刷新。

§1 执行摘要

  • Composite fair value $335 with high case $439.
  • Implied downside of 37.2% to fair value.
  • Moat 9/10 · confidence 79/100 · Mature compounder.
  • Currently screens above fair value, so patience matters more than entry speed.
Fair value
$335
Margin of safety
-59.3%
Confidence
79/100
Moat
9/10

Educational analysis only — not financial advice. Always do your own due diligence.

$533.92Price
Low $231.99
Mid $335.08
High $439.23

IDXX trades against a final fair-value range of $231.99-$439.23, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.

  • Razor-and-blade diagnostic instrument model
    Razor-and-blade diagnostic instrument model
  • High switching costs locking in
    High switching costs locking in veterinary clinics
  • Cycle upside
    Accelerating global pet humanization, increased diagnostic utilization per clinical visit, and ongoing margin expansion from software integration.

§2 看空情景

A prolonged macroeconomic downturn could reduce discretionary veterinary clinic traffic, stalling instrument placements and consumable volume growth, while a high starting valuation multiple compresses.

该论点可能失败的方式

Severe Valuation Compression

· High

Market recalibrates the extreme 39x trailing P/E multiple down to the model's 25x terminal multiple constraint.

FV impact
-37% to base case midpoint of $335.08

Macroeconomic Traffic Downturn

· Medium

A prolonged recession reduces discretionary veterinary clinic traffic, stalling instrument placements and recurring consumable volumes.

FV impact
Drives valuation toward the $231.99 bear case low

Margin Degradation

· Low

Competition forces aggressive pricing, causing operating margins to fall below the historically stable 30-31.6% range.

FV impact
Erodes 41.7% ROIC and compresses intrinsic fair value further
需关注的早期预警信号
指标当前触发阈值
Operating margins falling below 30% indicating pricing power erosion.MonitorDeterioration versus the report thesis
Consumables volume growth dropping below mid-single digits.MonitorDeterioration versus the report thesis
Deceleration in new point-of-care instrument placements.MonitorDeterioration versus the report thesis
Market-implied growth expectations failing to meet the 15.29% hurdle.MonitorDeterioration versus the report thesis
Terminal multiple compression accelerating toward the 25x model anchor.MonitorDeterioration versus the report thesis

§3 财务历史

损益表 — 最近六期
项目T−0T−1T−2T−3T−4CAGR
期间2021-12-312022-12-312023-12-312024-12-312025-12-31Trend
营业收入$3.22B$3.37B$3.66B$3.90B$4.30B+7.6%
毛利$1.89B$2.00B$2.19B$2.38B$2.66B+8.9%
营业利润$932.0M$898.8M$1.10B$1.13B$1.36B+9.9%
净利润$744.8M$679.1M$845.0M$887.9M$1.06B+9.2%
每股收益(摊薄)$8.03$10.06$10.67$13.08+13.0%
EBITDA$1.04B$1.01B$1.22B$1.27B$1.51B+9.8%
研发$161.0M$254.8M$191.0M$219.8M$251.2M+11.8%
销售管理费用$796.4M$850.8M$901.9M$1.03B$1.05B+7.1%

质量评分

OCF / 净利润
1.12×
>1 表示盈利质量高
会计质量门槛
Fail
经行业调整门槛
ROIC
41.7%
投入资本回报率
第 3 节

Numbers analysis

现金流

Cash-flow quality is reflected in the OCFOperating cash flowCash generated from the company's core operations after working-capital changes but before capital expenditures. The first line of the cash-flow statement. / net incomeNet IncomeNet Income is an income-statement line item used to reconcile revenue to operating profit, pre-tax income, net income, or per-share earnings. It should be compared across periods and against peer disclosure conventions., accounting-quality, and ROICROICReturn on invested capital. Operating profit (after tax) divided by invested capital. The single best gauge of capital-efficiency. Spread over WACC = economic value created. rows above.

资本配置

Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.

个人订阅用户 — §4 及之后还有 11 个章节

阅读完整分析 — 还有 11 个章节。

Competitive moat, industry cycle, peer comparison, intrinsic valuation, sensitivity, scenarios, earnings decision tree, position management, investor perspectives, scorecard, and final recommendation.

涵盖每个股票的完整报告
24 个月的评级存档
关注列表简报 + 评级变更提醒
以任意语言导出 PDF + DOCX
开始免费试用
可随时取消。
FAQ

IDXX — frequently asked questions

  1. Based on our latest analysis, IDXX looks meaningfully overvalued. The current price is $534 versus a composite fair-value midpoint of $335 (range $232–$439), which implies roughly 37.2% downside to the midpoint.
Related coverage

Names readers of IDXX also follow

Same archetype: mature-compounder